IL1B and familial Mediterranean fever: Introduction: Canakinumab, an inhibitor of interleukin-1 (IL-1b), has shown to be safe and effective in preventing attacks of familial Mediterranean fever (FMF) in individuals with colchicine-resistant (crFMF).